eyecare.png
 

what we invest in

Sanitas Ventures looks at “what is inevitable” in the next 5-7 years in the eye care industry, then seeks early-stage companies to partner with which are “accelerating the inevitable.”  First and foremost we invest in great teams- and a great team starts with exceptional founders. Great teams build great companies. Our other criteria include:

Large, Growing Markets: We invest in companies that have the potential to reach $25M in revenue five years after first commercial sale.

Unmet Needs: Addressing unmet needs gives a new company an unmatched advantage when it comes to going to market and scaling up.

Proprietary Technology: If you're going to build something great, you have to be able to protect it. Proprietary technologies make it possible to hold off the competition.

Contained Regulatory Risk: We prefer companies that have clear-cut commercialization pathways and low regulatory risk.

All Stages of Growth: Since we are a focused on eyecare exclusively, we are opportunistic in that we invest in companies at various stages of their development and commercialization

 

oeioel.png
DSC_4419_0.jpg
oeeel.png
 
 

Investors

Benefits to strategic limited partners:

  • Early visibility to emerging trends

  • Introductions to innovative companies of strategic interest

  • Regularly scheduled interactions to share ideas

  • Direct insight into pipeline, diligence findings, portfolio and companies of interest

  • Commercial relationship opportunities with portfolio companies

  • Potential co-investment opportunities

  • Friendly, informal networking opportunity with other strategic limited partners at Sanitas sponsored events

 
 
We are proud to invest on behalf of some of the worlds most influential eye care companies, retail chains, and doctor networks.
 
 

Through best practices refined from over two decades of working with these entities, we help spread innovation within our strategic investors’ organizations. In turn, they help accelerate the growth of our portfolio companies. They help us with due-diligence, developing targeted investment themes, and identifying dynamic companies working with their organizations that may need growth capital.

 

MG_8423.jpg
ddas.png
boulder_creek_path-2016-getty.jpg
 
 

Entrepreneurs

 
 

benefits to portfolio entrepreneurs:

  • Perspectives on innovation and emerging trends

  • Insights into prospective customer attitudes, pain point and hot buttons

  • Introductions for qualified commercial relationships

  • Talent and board member recruitment

  • A well-capitalized co-investor network

  • Heightened visibility with eyecare industry key constituents

  • Executable exit strategy expertise

In the early-stage venture, we invest to grow equity. We lead financing and participate as co-investors at various stages of growth. 

 

 
draw.png
 
 
 

relationships that set us apart

UNPARALLELED ACCESS

These symbiotic relationships will be a hallmark of our success. We enjoy longstanding relationships and regular interactions with the senior executives of our strategic investors. We serve on the Boards of Directors of a handful of other innovative and influential healthcare organizations. In addition, we continue to expand our relationships with newcomers in the emerging entrepreneurial eye care ecosystem.

MORE THAN JUST CAPITAL.

We do a lot more than invest capital. We can offer our portfolio companies one of the deepest networks in the world of eye care. We know what it takes to build successful companies, and we're willing to roll up our sleeves and help our portfolio teams succeed. With everything from go-to-market strategy, supply chain assistance, regulatory approvals, etc. we will help you accelerate growth.